On 2025-2-8 Global Info Research released【Global Therapeutic Drug Monitoring Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031】. This report includes an overview of the development of the Therapeutic Drug Monitoring industry chain, the market status of Consumer Electronics (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), Household Appliances (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Therapeutic Drug Monitoring.
According to our (Global Info Research) latest study, the global Therapeutic Drug Monitoring market size was valued at US$ 2207 million in 2024 and is forecast to a readjusted size of USD 3908 million by 2031 with a CAGR of 8.6% during review period.
Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs. Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
The Therapeutic Drug Monitoring (TDM) market is growing due to an increasing focus on personalized medicine, which tailors treatments to the individual characteristics of each patient. TDM enables clinicians to optimize drug dosages for better efficacy and reduced toxicity, particularly important for drugs with narrow therapeutic windows, such as immunosuppressants, anti-epileptics, and certain antibiotics. As the incidence of chronic diseases rises globally, there is greater demand for precise dosing in treatments, which supports TDM's expanding role. Additionally, technological advancements in laboratory automation and assay sensitivity are making TDM more accessible and accurate, further driving market growth.
A significant challenge in the TDM market is the high cost of testing and the need for specialized equipment and expertise, which can limit its accessibility, especially in lower-income regions. TDM requires sophisticated instruments and skilled personnel to interpret results accurately, leading to a barrier for healthcare facilities without sufficient resources. Furthermore, in some cases, there is a lack of standardized protocols for monitoring certain drugs, creating inconsistencies in practices across healthcare systems. These factors may hinder the widespread adoption of TDM, especially in resource-constrained settings.
Global therapeutic drug monitoring key players include Roche, Danaher and Abbott.The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45%.In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.
This report is a detailed and comprehensive analysis for global Therapeutic Drug Monitoring market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Sample Report Request Therapeutic Drug Monitoring
https://www.globalinforesearch.com/reports/2417460/therapeutic-drug-monitoring
Market segment by Type： Blood Test、Urine Test、Saliva Test
Market segment by Application：Hospital Labs、Independent Clinical Laboratories、Others
Major players covered： Roche、Danaher、Abbott、Thermo Fisher Scientific、Siemens Healthineers、Bio-Rad Laboratories、bioMerieux、Bühlmann Laboratories、Randox Laboratories、Sekisui Medical、DAT Diagnostic、Chromai
Market segment by region, regional analysis covers: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe), Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),South America (Brazil, Argentina, Colombia, and Rest of South America),Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Drug Monitoring product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Therapeutic Drug Monitoring, with price, sales, revenue and global market share of Therapeutic Drug Monitoring from 2020 to 2025.
Chapter 3, the Therapeutic Drug Monitoring competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Drug Monitoring breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2020 to 2024.and Therapeutic Drug Monitoring market forecast, by regions, type and application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Therapeutic Drug Monitoring.
Chapter 14 and 15, to describe Therapeutic Drug Monitoring sales channel, distributors, customers, research findings and conclusion.
Data Sources:
- Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
- Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
- Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
- Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.
- From our partners.We have information agencies as partners and they are located worldwide, thus we get (or purchase) the latest data from them.
- Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.